BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31782160)

  • 21. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity.
    Coindre JM; Hostein I; Maire G; Derré J; Guillou L; Leroux A; Ghnassia JP; Collin F; Pedeutour F; Aurias A
    J Pathol; 2004 Jul; 203(3):822-30. PubMed ID: 15221942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New defining body (Ugras body) in polypoid dedifferentiated liposarcoma of the vallecula. Histomorphological, immunohistochemical and molecular genetic findings.
    Ugras S; Miettinen M
    Indian J Pathol Microbiol; 2020; 63(3):449-452. PubMed ID: 32769337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours.
    Aleixo PB; Hartmann AA; Menezes IC; Meurer RT; Oliveira AM
    J Clin Pathol; 2009 Dec; 62(12):1127-35. PubMed ID: 19946100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of MDM2 Fluorescence In Situ Hybridization and Immunohistochemistry in Distinguishing Dedifferentiated Liposarcoma From Other High-grade Sarcomas.
    Song MJ; Cho KJ; Lee JS; Song JS
    Appl Immunohistochem Mol Morphol; 2017; 25(10):712-719. PubMed ID: 27028243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.
    Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F
    Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dedifferentiated Liposarcoma of the Gastroesophageal Junction.
    Aşkan G; Bağci P; Hameed M; Baştürk O
    Turk Patoloji Derg; 2018; 34(1):104-107. PubMed ID: 25690861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dedifferentiated liposarcoma with homologous lipoblastic differentiation: expanding the spectrum to include low-grade tumours.
    Liau JY; Lee JC; Wu CT; Kuo KT; Huang HY; Liang CW
    Histopathology; 2013 Apr; 62(5):702-10. PubMed ID: 23425231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanding the differential of cutaneous epithelioid tumors: A case of dedifferentiated liposarcoma with epithelioid features involving the skin, with review of the literature.
    Chambers M; Badin DJ; Sriharan AA; Linos KD
    J Cutan Pathol; 2020 Jun; 47(6):554-560. PubMed ID: 31995237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
    Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
    Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dedifferentiated Liposarcoma Masquerading as Rhabdomyosarcoma.
    Kobayashi A; Hirose T; Kudo E; Kawashita Y; Yagi T
    Appl Immunohistochem Mol Morphol; 2017; 25(5):e34-e36. PubMed ID: 27801731
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Casadei L; Calore F; Braggio DA; Zewdu A; Deshmukh AA; Fadda P; Lopez G; Wabitsch M; Song C; Leight JL; Grignol VP; Lev D; Croce CM; Pollock RE
    Cancer Res; 2019 Oct; 79(19):4911-4922. PubMed ID: 31387924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Retroperitoneal dedifferentiated liposarcoma with rhabdomyoblastic differentiation: a clinicopathological analysis].
    Liu L; Wang LH; Ren YB; Rao XS; Yang SM
    Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):94-98. PubMed ID: 29429159
    [No Abstract]   [Full Text] [Related]  

  • 33. Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down-regulation.
    Zuco V; Pasquali S; Tortoreto M; Brich S; Percio S; Dagrada GP; Colombo C; Sanfilippo R; Lauricella C; Gounder M; El Bezawy R; Barisella M; Dei Tos AP; Casali PG; Gronchi A; Stacchiotti S; Zaffaroni N
    J Exp Clin Cancer Res; 2021 Mar; 40(1):83. PubMed ID: 33648535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clarifying the Distinction Between Malignant Peripheral Nerve Sheath Tumor and Dedifferentiated Liposarcoma: A Critical Reappraisal of the Diagnostic Utility of MDM2 and H3K27me3 Status.
    Makise N; Sekimizu M; Kubo T; Wakai S; Hiraoka N; Komiyama M; Fukayama M; Kawai A; Ichikawa H; Yoshida A
    Am J Surg Pathol; 2018 May; 42(5):656-664. PubMed ID: 29309298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dedifferentiated liposarcoma of the spermatic cord with a hemangioendothelioma-like component: a case report and review of the literature.
    Okano S; Yamamoto H; Kono S; Fujii H; Shirabe K; Maehara Y; Oda Y
    Pathol Res Pract; 2013 Sep; 209(9):596-604. PubMed ID: 23910173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.
    Creytens D; Van Gorp J; Speel EJ; Ferdinande L
    Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-expression of MDM2 and CDK4 in transformed human mesenchymal stem cells causes high-grade sarcoma with a dedifferentiated liposarcoma-like morphology.
    Kim YJ; Kim M; Park HK; Yu DB; Jung K; Song K; Choi YL
    Lab Invest; 2019 Sep; 99(9):1309-1320. PubMed ID: 31160689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary cardiac dedifferentiated liposarcoma with homologous and heterologous differentiation: a case report.
    He D; Chen M; Chen H; Liao D; Wang X; Zhang Z; Zhang H
    Int J Clin Exp Pathol; 2015; 8(8):9662-6. PubMed ID: 26464734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary duodenal dedifferentiated liposarcoma: A case report and literature review.
    Kim NI; Lee JS; Choi C; Nam JH; Choi YD; Kim HJ; Kim SS
    World J Clin Cases; 2022 Feb; 10(6):2007-2014. PubMed ID: 35317136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromosome-12 copy number alterations and MDM2, CDK4 and TP53 expression in soft tissue liposarcoma.
    Segura-Sánchez J; González-Cámpora R; Pareja-Megia MJ; García-Escudero A; Galera-Ruiz H; López-Beltrán A
    Anticancer Res; 2006; 26(6C):4937-42. PubMed ID: 17214366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.